Questionable advertising of psychotropic medications and disease mongering
2006
Questionable Advertising of Psychotropic Medications
publication
Author Information
Author(s): Jeffrey R Lacasse, Jonathan Leo
Hypothesis
The combined silence of government regulation and professional associations contributes to disease mongering in psychiatric treatment advertising.
Conclusion
Consumer advertising for psychiatric medications often misrepresents the science behind mental health disorders, leading to increased medicalization and potential disease mongering.
Supporting Evidence
- Consumer advertising for medications often simplifies complex mental health issues.
- The FDA-approved product information for medications sometimes contradicts advertising claims.
- There is a lack of public discussion from professional associations about misleading advertisements.
Takeaway
Ads for mental health medications can make it seem like everyone has a problem that needs fixing, even when that's not true.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website